Protocol: PEDRO-150 Phase: III (of life) Design: Open-label, single-subject Enrollment: N = 1, global Sponsor: Self-funded (regrettably)
Actively recruiting (an employer)

When will Pedro get a job?

A prospective, open-label, single-subject employment trial. One participant, 150 days, a global search (subject is 100% mobile), and a primary endpoint every Medical Affairs leader understands: a signed offer letter. Interim analyses published weekly on LinkedIn.

Time on study

··· / 150 days
···until database lock (23 Dec 2026)
First subject in: 27 Jul0% of study elapsedLast day on study: 23 Dec

Interim efficacy analysis

Kaplan-Meier estimate: probability of remaining unemployed

ITT population (n=1). Phased by hiring funnel. Censoring for holidays, "we'll circulate internally", and ghosting.

Median time to offer: pending Critical path: enter an interview process by day 78 HR vs. quietly waiting: 0.42 (95% CI: trust me)

Working backwards from database lock: interview rounds take 4 to 7 weeks and offers take 2 to 4 more. Any process not started by day 78 cannot mathematically reach signature by day 150. The urgency is not a vibe. It is arithmetic.

Study design

Primary endpoint

Signed offer letter for a senior pharma role (Medical Affairs leadership or adjacent commercial strategy). Assessed continuously. No surrogate endpoints. A "strong pipeline of conversations" does not pay rent.

Secondary endpoints

  • Warm introductions ≥ 1 per week
  • Interview processes entered before day 78
  • LinkedIn reshares of the weekly market post
  • Recruiters who reply within one calendar year

Enrollment: global

Open worldwide. Subject is fully mobile and relocation is not a barrier. Initial recruiting sites:

  • 🇸🇬 Singapore  🇹🇭 Thailand  🇦🇪 UAE
  • 🇨🇭 Switzerland  🇵🇹 Portugal  🇧🇷 Brazil
  • 🌍 Additional sites activated on employer interest

Inclusion criteria (for employers)

  • Has headcount, or is willing to invent some
  • Believes capability beats boxes ticked
  • Reads a CV in under 7 seconds and gets it
  • One introduction beats a hundred applications

Cast your prediction

Pick the day the primary endpoint is met. Your bet is saved on this device and copied for posting. The comments section is the real prediction market.

Adverse events log

  • Grade 1: "We've decided to move forward with other candidates." Frequency: common. Ongoing.
  • Grade 2: Application portals requesting the CV be retyped, field by field, after uploading the CV. Causality: definitely related.
  • Grade 2: "Let's keep in touch" (no further contact recorded). Resolved with coffee.
  • Serious adverse events: none. Subject remains in excellent spirits and dangerously well-networked.